In-111 DTPA and Moxetumomab Pasudotox-tdfk
Determining the interaction of In-111 DTPA and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: indium pentetate in-111
Brand name:
Synonyms: Pentetate Indium Disodium In 111
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- In-111 DTPA-Moxetumomab pasudotox-tdfk Intravenous
- In-111 DTPA-Moxifloxacin
- In-111 DTPA-Moxifloxacin (Systemic)
- In-111 DTPA-Moxifloxacin Hydrochloride
- In-111 DTPA-Moxifloxacin Injection
- In-111 DTPA-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Inamrinone
- Moxetumomab Pasudotox-tdfk-Inapsine
- Moxetumomab Pasudotox-tdfk-Inatal Advance
- Moxetumomab Pasudotox-tdfk-Inatal Ultra
- Moxetumomab Pasudotox-tdfk-Inbrija
- Moxetumomab Pasudotox-tdfk-Incassia